Immutable evidence record · ticker

NervGen Pharma Corp. (NGEN)

Published as observed on 17 August 2026 at 17:15 BST.

NervGen Pharma Corp. has a balanced company news read. Its latest completed weekly trend is negative.

As of
17 Aug 2026, 17:15
Scope
company and instrument
Evidence
6 items
Independent sources
2
Country
United States
Sector
Healthcare
Previous read
49.000
Change
1.000

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, NervGen Pharma Corp. (NGEN), 2026-08-17, https://sharemaestro.com/evidence/44195666-b8a7-4f4c-a10a-070223568cce/
Record checksum 72ae64babb3ab755250291be66ab748667a1e47880acc4c1cdc1e071fd2fc5c9

Evidence context